Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | N/A |
| PEG Ratio (TTM) | -7.11 | N/A |
| P/S Ratio (TTM) | 2.66 | N/A |
| P/B Ratio (TTM) | 1.34 | N/A |
| P/FCF Ratio (TTM) | 11.28 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.73 | N/A |
| Price to 5YR AVG FCF Ratio | 15.04 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.59% | N/A |
| ROE (TTM) | 7.87% | N/A |
| Net Profit Margin (TTM) | 14.85% | N/A |
| ROIC 5YR AVG | 17.22% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 219.91% | 18.68% | 6.80% |
| Revenue | 4.95% | 27.41% | 14.92% |
| Net Income | 221.89% | 33.99% | 17.53% |
| Cash Flow | 27.90% | 774.05% | 573.76% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 16.37 | N/A |
| Quick Ratio (TTM) | 16.37 | N/A |
| D/E Ratio (TTM) | 0.15 | N/A |
| Interest Coverage (TTM) | 4.72 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.40 | N/A |
| LTL to 5YR AVG FCF | 0.93 | N/A |
| Shares Outstanding Growth 5YR AVG | 9.04% | N/A |